Lifelines Neurodiagnostics Logo

Incereb neon Solves Concerns with Neonates

Troy, Illinois—(May 5, 2017) Lifelines Neurodiagnostic Systems, Inc.

It is becoming the industry standard to consistently monitor the neurological health of neonates.  EEG is critical to document subclinical seizures, but in addition to an EEG appearing invasive to already frightened parents, electrode application techniques may also cause health concerns for their newly born baby. 

According to ASET Professional Standards and Best Practices, the required equipment and preparation of an EEG can cause ulcers from device or adhesive pressures, injury due to swelling under circumferentially applied devices, skin breakdown, and infections[1].   

In the simplest terms, disk electrodes using a paste or gel adhesive are preferred, but breakdown of the skin, even tearing from removing tape, can lead to infections that these tiny babies are more susceptible to contracting.  

Lifelines has a solution for these concerns.  Incereb neon is an FDA-approved device, designed as one, single electrode array.  The neon lessens the discomfort for the baby, has a gentle conductive paste that is well-tolerated on delicate skin, and has a clean, sleek design that is less frightening to parents.

 

Learn more about Lifelines’ Incereb neon on our website here.

Incereb Neon


ASET Position Statement

Skin Safety During EEG Procedures – A Guideline to Improving Outcome

Addendum: Neonatal Continuous EEG

The Skin Safety Guideline developed by the Skin Safety Task Force (SSTF) and approved by the ASET Board of Trustees in 2015 provides instruction in attaching surface electrodes for continuous electroencephalogram (EEG) on adults. In 2016, the task force determined additional guidelines would be beneficial for patient subgroups, such as pediatrics, neonates, and those with skin conditions. The SSTF was directed to develop addenda for the existing guideline to address these special patient groups. Due to the level of work established by the previous task force, it was determined to be advantageous to form separate subcommittees to address each issue. The SSTF began with developing addenda for neonates and patients with dermatologic skin conditions; this addendum addresses neonatal patients undergoing continuous EEG.  

Neonatal EEG is defined as an EEG performed between birth and the first 4 weeks of life up to and including 44 weeks gestational age. Many of these patients are premature and may have serious or even life threatening complications. It is crucial that EEG Technologists do not cause additional injury to these patients through over preparation of the skin, failure to monitor the skin condition around and under the electrodes, or failure to respond quickly to changes in the condition of the skin.

It is important that every technologist understand and document the infant’s age according to the following terms in order for physicians to properly evaluate the EEG of neonates.

  • Gestational age (GA) – time in weeks from conception to the infant’s birth
  • Conceptional age (CA) – GA plus time in weeks since birth
  • Premature infant – born before 38 weeks GA
  • Full-term infant – born 38–40 weeks GA
  • Newborn period - first 4 weeks after term
  • Infantile period - between 5 and 12 weeks after term

 

 

Read the full ASET article here


[1] ASET Board of Trustees. Skin Safety During EEG Procedures – A Guideline to Improving Outcome. Position Statement.  Kansas City: ASET - The Neurodiagnostic Society, 2016. Document.